We previously demonstrated that cells can be killed through transfection of an expression plasmid that encodes the diphtheria toxin A-chain fragment (DT-A). This report describes the construction of expression plasmids containing three mutant DT-A-coding sequences substituting glutamic acid 148 with aspartic acid, serine, or glutamine which are known to have 100-to 300-fold-reduced ADP-ribosylation activity measured in vitro. The Diphtheria toxin (DT) consists of two functional units, the A and B chains, which produce toxicity to eukaryotic cells via B-chain-mediated binding to cellular receptors, internalization, and A-chain-mediated ADP-ribosylation of elongation factor 2 (4, 7, 15, 21). Wild-type DT is sufficiently toxic that a single molecule can cause cell death (22) .
Diphtheria toxin (DT) consists of two functional units, the A and B chains, which produce toxicity to eukaryotic cells via B-chain-mediated binding to cellular receptors, internalization, and A-chain-mediated ADP-ribosylation of elongation factor 2 (4, 7, 15, 21) . Wild-type DT is sufficiently toxic that a single molecule can cause cell death (22) .
We have previously demonstrated, both in cell culture (11, 13) and in transgenic mice (2, 3, 14) , that directed expression of the gene that encodes the DT A chain (DT-A) can result in selective destruction of a targeted cell population when the DT-A struotural gene is linked with tissue-specific transcriptional regulatory elements. To address the potential problem of undesirable leaky expression which might produce toxicity in nontargeted tissues, mutants of DT-A with attenuated toxicity might be employed. Site-directed mutagenesis has been used to produce changes in the DT-A-coding sequence, resulting in mutants with reduced ADP-ribosylation activity as measured in vitro (18, 20) . This report describes the construction of a series of expression plasmids containing these mutant coding sequences and assay of their activity upon transfection into two commonly used cell lines.
MATERIALS AND METHODS
DT-A plasmid constructions. Standard cloning methods were employed (10), and plasmids grown in Escherichia coli HB101 were isolated. Construction of pTH1, the prototype plasmid containing the wild-type DT-A-coding sequence linked to a truncated metallothionein promoter, has already been described (13) . A DT mutant, tox 176, generated by Uchida et al. (19) , was previously used in this laboratory to construct pTH1-176. Cotransfection experiments with 293 cells using a chloramphenicol acetyltransferase reporter plasmid showed diminished inhibition of chloramphenicol * Corresponding author.
acetyltransferase expression compared with wild-type DT-A (11). One of us (R.J.C.) has recently generated three additional DT-A mutants by site-directed mutagenesis (18, 20) , and these mutants were used as pBR322-derived bacterial expression plasmids (designated pTACF2E148D, pTAC F2E148S, and pTACF2E148Q) to construct the eukaryotic expression vectors described below. Reductions in ADPribosylation activity as measured in cell-free systems were 100-, 300-, and 250-fold for plasmids pTACF2E148D, pTAC F2E148S, and pTACF2E148Q, respectively (18, 20) . These plasmids contain the full-length DT-A-coding sequence with mutations at the codon for amino acid 148 in DT-A. Sau3Al sites are located 82 nucleotides 5' of codon 1 for mature DT-A and at the last codon in the DT-A region. A 5 ,ul of water) for electroporation in 0.4-cm presterilized disposable cuvettes (BioRad). The DNA solutions contained 5 jig of the reporter plasmid, pSV2A/L-AA5', a plasmid which produces large amounts of luciferase after transfection (5); the indicated amounts of the DT-A plasmid being tested; and a DT-A frameshift plasmid (pTH2) (13) as carrier DNA to render the total amount of DNA added constant. Capacitance settings on the Bio-Rad Gene Pulser were chosen so as to deliver a discharge with a time-constant readout of about 30 ms. The samples were then incubated at room temperature for 20 to 40 min before dilution into prewarmed medium and incubation at 37°C in an atmosphere containing 6% (vol/vol) CO2. The cells were sampled and assayed for luciferase after a 24-h expression period (12) .
Sequencing. The final expression plasmids were sequenced through the regions containing the mutated codon by using the method of Kraft et al. (8) for sequencing of doublestranded templates. Sequence data were generated by using the dideoxy method with Sequenase as the DNA polymerase (17) . All sequences were as predicted by the construction strategy.
Statistics. The percentage of control luminescence observed by log dose linear relationships was tested for each of the plasmids. Linear regressions were used to estimate LI50 (50% luminescence inhibition) values for each plasmid and the associated 95% confidence intervals (9). Figure 1 shows the important features of pTH1, the prototype DT-A expression plasmid, and demonstrates the position of the mutations in the E148 series plasmids, as well as the ADP-ribosylation activity of the DT-A mutant protein in cell-free assays (18, 20) . The sequence of codon 148 in the final plasmid constructions was verified by independent sequencing.
RESULTS
Luciferase reporter activity was initially obtained with each plasmid, cotransfected at a dose of 300 ng plus 2,700 ng of plasmid pTH2, as well as control values obtained with 3,000 ng of plasmid pTH2 containing a frameshift mutation in the DT-A-coding sequence. Lysates from control cells produced 478,000 light U/100 ,ug of protein for HeLa cells and 162,000 light U/100 ,ug of protein for 293 cells. Inhibition of this expression by the various plasmids ranged from 23 to 72% in HeLa cells and from 22 to 74% in 293 cells. Figure 2A and B are plots of the percentage of control luminescence against the log of the DNA dose in nanograms, in HeLa and 293 cells, respectively, while Table 1 provides an analysis of the LI50s of different plasmids. As the figure illustrates, each expression plasmid demonstrated dosedependent inhibition of luciferase expression over the range of 0.3 to 3,000 ng. The calculated slopes of these curves were significantly different (P < 0.0001 by the Procedure-General Linear Models from the Statistical Analysis System program [9] ). The mutant plasmids showed attenuated levels of inhibition over this dose range compared with the wild-type activity of pTH1. The relative order of attenuated toxicity was nearly as predicted by reductions in ADP-ribosylation (16) , is joined to a 5' truncated metallothionein (MT) promoter fragment (13) which also supplies the ATG initiation codon. Poly(A) signal (AATAAA), t splice (SV40 splice), and AMPR (ampicillin resistance gene) locations are shown along with map positions and restriction enzyme sites. The codon sequence for position 148 is given. ADP-ribosylation activity is shown as previously reported (18, 20) . WT, wild type; ori, origin. activity measured in cell-free systems, with the only discrepancy being that E148S was slightly more toxic than E148Q, while the opposite was true for the comparison of their ADP-ribosyltransferase activities (20) .
DISCUSSION
The data presented in this report extend our observations on the use of DT mutants to obtain attenuation of toxicity of cellular expression vectors. The cotransfection assay provides a convenient means of testing transiently expressed mutant protein, since overall protein synthesis in cell cultures might be reduced to a lesser extent on the basis of efficiency of transfection.
Linear regression analysis also allowed us to estimate the plasmid LI50 (Table 1 ). These estimates gave a 39-fold difference and a 150-fold difference between the most toxic plasmid (pTH1) and the most attenuated mutant (pTH1-E148Q) in HeLa cells and 293 cells, respectively. The magnitude of reduction in toxicity for the codon 148 series of mutants was less than expected. The trivial explanation that mutation revertants or laboratory error could account for this phenomenon was eliminated by sequencing the mutation site of each of the final plasmid constructions (see Materials and Methods). ADP-ribosylation activity, as measured in cell-free assays, provides a measurement of enzyme activity, whereas cotransfection experiments introduce a number of additional variables. It is possible that the diphtheria toxin gene product controls its own synthesis in a feedback fashion, such that more of the attenuated DT-A protein is allowed to accumulate before it inhibits its own synthesis. This may allow the activity of the more attenuated toxin to increase relative to that of the wild-type toxin. We gratefully acknowledge the cooperation of Sharon Byrne for preparation of the manuscript.
